www.medical-devices.tech
04
'25
Written on Modified on
Smith+Nephew Announces US Launch of CENTRIO Platelet-Rich-Plasma System
The CENTRIO PRP System supports natural healing for chronic wounds, including diabetic foot, venous leg, pressure, and tunneling ulcers, by maintaining a moist, biodynamic wound environment.
www.smith-nephew.com
Smith+Nephew, the global medical technology company, announces the launch of the CENTRIO Platelet-Rich-Plasma (PRP) System, a biodynamic hematogel derived from a patient’s own platelets and plasma that, once applied, may assist the natural healing process by maintaining a moist wound environment.
CENTRIO PRP System can help manage chronic exuding wounds, including but not limited to diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers, and tunnelling wounds. Thanks to a National Coverage Determination (NCD) made effective April 2021, autologous PRP for the treatment of chronic non-healing wounds for diabetic patients has CMS coverage, when prepared by devices whose indications include the management of exuding cutaneous wounds, such as diabetic ulcers. The CENTRIO PRP System is designed for point-of-care use in both hospital and physician office settings, and the gel can be tailored to fit wound shape, depth, and stage with a single draw of a patient’s blood. CENTRIO PRP System has demonstrated efficacy in two randomized, controlled clinical trials, making it a strong fit in Smith+Nephew’s clinically proven portfolio.
Vincent Fath, SVP US Advanced Wound Management, Smith+Nephew, commented:
“CENTRIO PRP System sits perfectly alongside our portfolio of skin substitutes to offer a broad portfolio of proven biological solutions that augment healing outcomes backed by extensive clinical evidence. We are pleased to be able to expand access to this exciting and highly differentiated technology to help ease the burden of living with hard-to-heal wounds.”
The CENTRIO PRP System will premiere at the Smith+Nephew booth (#411) during the Symposium on Advanced Wound Care (SAWC) Fall Conference in Las Vegas, Nevada, from September 3-6.
Smith+Nephew entered into an exclusive private label distribution agreement with Nuo Therapeutics Inc., a commercial-stage medical device company pioneering biodynamic therapies, to market the CENTRIO PRP System in the United States.
www.smith+nephew.com
